Apr 30 |
Regulus Therapeutics to Participate in the Canaccord Genuity Genetic Medicine for Generalists Webcast Series
|
Apr 10 |
Regulus: It Is Finding Its Stride Despite Initial Setback In Targeting ADPKD
|
Apr 9 |
Regulus files to sell 62.5M shares of common stock for holders
|
Mar 23 |
Regulus Therapeutics Inc (RGLS) Reports Year-End Earnings, Highlights Key Clinical Advancements
|
Mar 21 |
Regulus Therapeutics GAAP EPS of -$0.40 in-line
|
Mar 21 |
Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates
|
Mar 14 |
Biotech Stock Roundup: AMLX, ACAD Down on Study Data, MRNA, RGLS Gain on Updates & More
|
Mar 13 |
Regulus (RGLS) Up 71% on Topline Data from Kidney Disease Study
|
Mar 12 |
Regulus Therapeutics stock up on $100M private placement of equity
|
Mar 12 |
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity
|